Skip to content

Clinical trials

Phase 2 Spasm trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Spasm Phase: Phase 2 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20122
20131
20172
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Flex Pharma, Inc.2
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
National Institute of Neurological Disorders and Stroke (NINDS)1
Neurana Pharmaceuticals, Inc.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Rachel G. Greenberg, MD, MB, MHS1
Raymond Foster1
Salient Pharmaceuticals Incorporated1
The University of Texas Health Science Center, Houston1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Spasm10
Muscle Cramp3
Attention Deficit Disorder with Hyperactivity2
Nervous System Diseases2
Neurodegenerative Diseases2
Neuromuscular Diseases2
Acute Pain1
Amyotrophic Lateral Sclerosis1
Autism Spectrum Disorder1
Back Pain1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.